缩宫素联合卡孕栓预防产后出血的临床疗效

Clinical efficacy analysis of oxytocin combined with methyl carboprost suppositories in the prevention of postpartum hemorrhage

目的:探讨缩宫素联合卡孕栓预防产后出血的临床疗效。方法:收治阴道分娩产妇100例,分两组,观察组给予缩宫素联合卡孕栓预防,对照组单纯给予缩宫素预防,对比两组相关指标。结果:观察组产后2 h、24 h出血量均显著低于对照组,第三产程时间明显快于对照组,差异有统计学意义(P<0.05);观察组出现腹泻和便意3例,出现恶心、呕吐2例,但2~3 h后自动消失,对照组未发生不良反应。结论:缩宫素联合卡孕栓预防产后出血的临床疗效满意,可减少产后出血量,缩短第三产程,安全性高。

Objective：To investigate the clinical effect of oxytocin combined with methyl carboprost suppositories in preventing postpartum hemorrhage.Methods：100 cases of vaginal deliveries were divided into the two groups.The observation group was given oxytocin combined with methyl carboprost suppositories and the control group was given oxytocin prevention alone.The relative indexes of the two groups were compared.Results：The bleeding volume at 2 and 24 hours postpartum was significantly lower in the observation group than in the control group.The time of the third stage was significantly faster than that of the control group,and the differences were statistically significant（P〈0.05）.The diarrhea and constipation were observed in the observation group in 3 cases.Maternal nausea and vomiting occurred in 2 cases but disappeared after 2~3 hours.No adverse reactions occurred in the control group.Conclusion：The clinical effect of oxytocin combined with methyl carboprost suppositories to prevent postpartum hemorrhage is satisfactory.It can reduce postpartum hemorrhage,shorten the third stage of labor and has high safety.